Translating research into improved outcomes in comprehensive cancer control.
A key question in moving comprehensive cancer control (CCC) plans into action is, to what extent should the knowledge gained from investments in cancer prevention and control research influence the actions taken by states, tribes, and territories during implementation? Underlying this 'should' is the assumption that evidence-based approaches (i.e., a public health or clinical intervention or policy that has resulted in improved outcomes when scientifically tested), when implemented in a real-world setting, will increase the likelihood of improved outcomes. This article elucidates the barriers and opportunities for integrating science with practice across the cancer control continuum. However, given the scope of CCC and the substantial investment in generating new knowledge through science, it is difficult for any one agency, on its own, to make a sufficient investment to ensure new knowledge is translated and implemented at a national, state, or local level. Thus, if greater demand for evidence-based interventions and increased resources for adopting them are going to support the dissemination initiatives described herein, new interagency partnerships must be developed to ensure that sufficient means are dedicated to integrating science with service. Furthermore, for these collaborations to increase both in size and in frequency, agency leaders must clearly articulate their support for these collaborative initiatives and explicitly recognize those collaborative efforts that are successful. In this way, the whole (in this context, comprehensive cancer control) can become greater than the sum of its parts.
Kerner
Jon F
JF
Division of Cancer Control and Population Sciences, National Cancer Institute, 6130 Executive Blvd. EPN 6144, Bethesda, MD 20892, USA. kernerj@mail.nih.gov
Guirguis-Blake
Janelle
J
Hennessy
Kevin D
KD
Brounstein
Paul J
PJ
Vinson
Cynthia
C
Schwartz
Randy H
RH
Myers
Bradford A
BA
Briss
Peter
P
D035843:Biomedical Research; D015510:Clinical Medicine; D019317:Evidence-Based Medicine; D014943:Global Health; D006801:Humans; D033181:Information Dissemination; D009369:Neoplasms / Q000517:prevention & control*; D011315:Preventive Medicine